GSK Bets Big on Better Biological Data for AI
GSK just signed a new deal with a company called Relation Therapeutics. They want to improve how AI finds new drugs by using higher quality information. The partnership is worth up to 110 million dollars.
The main problem with many AI drug projects is that they lack good data. Relation will now build massive databases showing exactly how human cells react to different drugs and genetic changes. This creates a much clearer map for the AI to follow.
Better data leads to better results in the lab. By focusing on real biological reactions instead of guesses, the companies hope to build more reliable medicines. This shows that having the right information is more important than just having a fast computer.
Comments (0)
No comments yet. Be the first!
More AI news
NewsNew AI Tool Fixes Mistakes in Financial Research
Researchers developed a new framework to stop AI from learning from its own bad data in financial trading models.
NewsPerplexity adds local AI to Mac apps
The new update lets your Mac handle some AI tasks directly on your computer.
NewsMeta Releases Muse Image Model on Fal
Meta has launched a new AI model on the Fal platform that plans and edits images on its own.